https://www.selleckchem.com/pr....oducts/thiomyristoyl
1% (12/21) vs. 26.3% (10/38); P = .026]. The median PFS in group A was significantly longer than in group B [11.0 (95% CI 7.9-16.2) months vs. 5.2 (95% CI 3.7-7.9) months; P = .001]. However, the median OS was not significantly different [27.7 (95% CI 20.6-44.4) months vs. 17.7 (95% CI 14.5-27.5) months; P = .152]. CONCLUSION Systemic therapy plus thermal ablation may prolong PFS but not OS in oligometastatic LMs from NSCLC.BACKGROUND The number of elderly patients diagnosed with hepatocellular carcinoma (HCC) is progressively inc
Like
Comment
Share
